is zepbound and semaglutide the same thing users lost nearly 50% more weight than those on Wegovy in first head-to-head study Zepbound Versus Wegovy: Head-to-Head Trial

Originally approved by the Food and Drug Administration (FDA) to help manage type 2 diabetes, some GLP-1 medications are now FDA approved to help manage obesity and help with weight loss

Government inspectors audit laboratory activities and records against these regulations, often focusing on adherence to GLP studies and the involvement of the quality assurance unit

GLP-1 effects on cholesterol vary by individual baseline status, medication type, and dosage

Scratching images were obtained with a light Olympus microscope

Yamaoka H, Sasaki H, Yamasaki H, et al

Mounjaro (tirzepatide) is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus in adults